Seed sclerotinia
Sclerotinia spermophila
Description
The causal agent of this disease is the fungus Sclerotinia spermophila, a member of the Ascomycota division. This pathogen is specifically adapted to infect the reproductive tissues of plants, particularly focusing on the seeds. It is classified as a type of sclerotinia rot, characterized by its ability to cause severe deterioration of developing seeds and pods.
The disease primarily affects various legume species, such as clover and alfalfa, which are commonly grown for forage and seed production. The fungus invades the floral parts, eventually settling in the developing seeds. This infection pattern significantly undermines the agricultural value of the seeds, often rendering them non-viable for future sowing.
Symptoms of the infection become visible as the plant reaches maturity. Affected pods may show a distinct white, cotton-like mycelial growth. As the disease progresses, the fungus produces hard, black resting structures known as sclerotia within the pods, effectively replacing the healthy seed tissue. These structures are crucial for the long-term survival of the pathogen in the field.
Environmental conditions play a critical role in the development and spread of Sclerotinia spermophila. Cool, humid conditions combined with frequent rainfall during the seed-filling stage create an ideal environment for spore germination and infection. High moisture levels allow the fungus to proliferate rapidly, potentially leading to significant field outbreaks.
The economic impact of the disease is substantial due to direct yield losses and reduced seed quality. Effective management strategies are essential to mitigate these risks:
- Prioritize the use of high-quality, pathogen-free certified seeds.
- Implement diverse crop rotation programs to break the pathogen's life cycle.
- Ensure thorough removal or deep incorporation of crop residues into the soil.
- Apply targeted fungicide treatments during the flowering stages when conditions are favorable for disease.
Products · 0
Discussion
No discussions yet — be the first.